PE20011009A1 - Proceso para recubrir nucleos de tabletas - Google Patents

Proceso para recubrir nucleos de tabletas

Info

Publication number
PE20011009A1
PE20011009A1 PE2000001245A PE0012452000A PE20011009A1 PE 20011009 A1 PE20011009 A1 PE 20011009A1 PE 2000001245 A PE2000001245 A PE 2000001245A PE 0012452000 A PE0012452000 A PE 0012452000A PE 20011009 A1 PE20011009 A1 PE 20011009A1
Authority
PE
Peru
Prior art keywords
coating
suspension
refers
tablet cores
coating tablet
Prior art date
Application number
PE2000001245A
Other languages
English (en)
Inventor
Herwig Jennewein
Reinhard Entner
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3525424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20011009(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of PE20011009A1 publication Critical patent/PE20011009A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glanulating (AREA)

Abstract

SE REFIERE A UN PROCESO PARA RECUBRIR NUCLEOS DE TABLETAS QUE CONTIENE UN PRINCIPIO ACTIVO DE SABOR DESAGRADABLE TAL COMO CEFUROXIMA-AXETIL, CEFPODOXIMA-PROXETIL, AMOXICILINA, SUMATRIPTANO, OLANZAPINA; QUE COMPRENDE ROCIAR UNA SOLUCION O SUSPENSION DE RECUBRIMIENTOS DE AZUCAR O ALMIDON, O UNA MEZCLA DE AMBOS; O AGENTES DE DIVISION, PIGMENTOS, COLORANTES, EDULCORANTES, SABORIZANTES, HUMECTANTES, CONSERVADORES, LUBRICANTES, ANTIESPUMANTES SOBRE LOS NUCLEOS; CON LA CONDICION QUE SE EXCLUYAN AGENTES FORMADORES DE PELICULA EN LA SOLUCION O SUSPENSION DE RECUBRIMIENTO; TAMBIEN SE REFIERE A UNA TABLETA RECUBIERTA; UNA MEZCLA DE RECUBRIMIENTO
PE2000001245A 1999-11-23 2000-11-22 Proceso para recubrir nucleos de tabletas PE20011009A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198899A AT500063A1 (de) 1999-11-23 1999-11-23 Beschichtete tablettenkerne

Publications (1)

Publication Number Publication Date
PE20011009A1 true PE20011009A1 (es) 2001-10-18

Family

ID=3525424

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001245A PE20011009A1 (es) 1999-11-23 2000-11-22 Proceso para recubrir nucleos de tabletas

Country Status (29)

Country Link
US (1) US8652517B2 (es)
EP (1) EP1231903B1 (es)
JP (1) JP2003514848A (es)
KR (1) KR20020059771A (es)
CN (1) CN1391465A (es)
AR (1) AR026560A1 (es)
AT (2) AT500063A1 (es)
AU (1) AU776662B2 (es)
BR (1) BR0015449A (es)
CA (1) CA2387575A1 (es)
CO (1) CO5261638A1 (es)
CZ (1) CZ20021765A3 (es)
DE (1) DE60025536T2 (es)
EC (1) ECSP003781A (es)
ES (1) ES2255521T3 (es)
HK (1) HK1049786A1 (es)
HU (1) HUP0204072A3 (es)
IL (1) IL149189A0 (es)
MX (1) MXPA02005195A (es)
NO (1) NO20022362L (es)
NZ (1) NZ518524A (es)
PE (1) PE20011009A1 (es)
PL (1) PL354456A1 (es)
RU (1) RU2002116225A (es)
SK (1) SK6962002A3 (es)
TR (1) TR200201028T2 (es)
TW (1) TW579298B (es)
WO (1) WO2001037816A2 (es)
ZA (1) ZA200203654B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03007678A (es) * 2001-02-27 2004-03-16 Ranbaxy Lab Ltd Composicion farmaceutica oral de proxetil cefpodoxima.
US20030072729A1 (en) * 2001-05-15 2003-04-17 Christopher Szymczak Simethicone as weight gain enhancer
GB2380936B (en) * 2001-10-18 2003-07-09 Reckitt Benckiser Healthcare Improvements in or relating to compositions
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
CN1681493A (zh) * 2002-07-19 2005-10-12 兰贝克赛实验室有限公司 掩味舒马曲坦片剂及其制备方法
KR20040011087A (ko) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
KR20140117678A (ko) 2006-01-06 2014-10-07 루이트폴드 파머수티컬스, 인코퍼레이티드 철을 투여하기 위한 방법 및 조성물
EP2042164A4 (en) * 2006-06-23 2010-10-13 Takeda Pharmaceutical STABILIZED SOLID PREPARATION
JPWO2007148772A1 (ja) * 2006-06-23 2009-11-19 塩野義製薬株式会社 マクロライド系抗生物質の糖類被覆製剤
WO2008057058A1 (en) * 2006-11-10 2008-05-15 Nobel Ilac Sanayii Ve Ticaret As Oral pharmaceutical compositions
JP5248060B2 (ja) * 2007-08-17 2013-07-31 興和株式会社 シリコーンを配合した糖衣製剤およびその製造方法
DE202009007393U1 (de) 2009-02-25 2010-07-22 Sensient Food Colors Germany Gmbh Dragiermittel zum Dragieren von Arzneimitteln und Lebensmitteln
CN102266304B (zh) * 2010-06-04 2012-12-26 瑞阳制药有限公司 苯唑西林薄膜衣片的制备方法
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物
EP2833873A1 (en) * 2012-04-04 2015-02-11 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
EP2882423A1 (en) 2012-08-07 2015-06-17 Sandoz AG Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide
JP2014227406A (ja) * 2013-05-27 2014-12-08 株式会社ウメケン 苦味生薬含有粒状物
JP6031730B2 (ja) * 2014-12-19 2016-11-24 株式会社東洋新薬 経口剤、経口剤の製造方法、経口固形剤のコーティング用組成物
CN108815130A (zh) * 2018-08-27 2018-11-16 邓倩 一种头孢泊肟酯药片及其生产工艺
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB407919A (en) * 1932-06-24 1934-03-29 Ig Farbenindustrie Ag Improvements in or relating to the manufacture of shaped medicinal preparations
US3185628A (en) * 1960-03-18 1965-05-25 Nopco Chem Co Sunscreening dihydroxy-diphenylsulfone derivatives
US3185626A (en) * 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3361631A (en) 1963-09-30 1968-01-02 Sandoz Ag Method of sugar coating pharmaceutical tablets
JPS4837815B1 (es) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
GB1318757A (en) 1970-11-16 1973-05-31 Yamanouchi Pharma Co Ltd Method of sugar coating tablets
US3751277A (en) * 1971-03-24 1973-08-07 Dow Chemical Co Tablet coating process and composition
US3753767A (en) * 1971-08-02 1973-08-21 Colgate Palmolive Co Method of sugar-coating tablets
US4238510A (en) * 1979-02-21 1980-12-09 Life Savers, Inc. Sugarless coating for chewing gum and confections and method
JPS5850968B2 (ja) * 1979-04-12 1983-11-14 フロイント産業株式会社 糖衣の製法
DE2936040C2 (de) * 1979-09-06 1982-05-19 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Dragierverfahren und Mittel zur Durchführung des Verfahrens, bestehend im wesentlichen aus Saccharose, wenigstens einem weiteren Zucker und Wasser
CA1168082A (en) * 1979-10-17 1984-05-29 Francis Devos Hard coating process with sorbitol and products so-obtained
JPS57134414A (en) * 1981-02-13 1982-08-19 Nikken Kagaku Kk Preparation of sugar-coated tablet
IT1214875B (it) * 1984-06-21 1990-01-18 Ferrero Spa Prodotto confettato e procedimento per la sua fabbricazione
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
GB8419575D0 (en) 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2580904B1 (fr) * 1985-04-30 1990-08-10 Roquette Freres Produit de confiserie ou pharmaceutique a revetement sans sucre obtenu par drageification dure et son procede de preparation.
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
DD273000A1 (de) * 1988-06-20 1989-11-01 Univ Halle Wittenberg Verfahren zur herstellung von ueberzuegen auf arzneiformen
GB9104890D0 (en) 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
DE4236025A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5759577A (en) 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19503670C2 (de) * 1995-01-25 1997-07-31 Lichtwer Pharma Gmbh Dragiersuspension und Verfahren zur Herstellung der Dragees
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
EP0996508B1 (en) * 1997-01-06 2004-08-11 BPSI Holdings, Inc. Film coatings and film coating compositions based on dextrin
US6221402B1 (en) * 1997-11-20 2001-04-24 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
JP2002510716A (ja) * 1998-04-02 2002-04-09 ジェネンコア インターナショナル インコーポレーテッド 修飾デンプンコーティング
DE19826517B4 (de) 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette

Also Published As

Publication number Publication date
EP1231903A2 (en) 2002-08-21
DE60025536D1 (de) 2006-04-06
ECSP003781A (es) 2002-04-23
CZ20021765A3 (cs) 2002-08-14
KR20020059771A (ko) 2002-07-13
PL354456A1 (en) 2004-01-12
HK1049786A1 (zh) 2003-05-30
WO2001037816A2 (en) 2001-05-31
EP1231903B1 (en) 2006-01-11
AT500063A1 (de) 2005-10-15
JP2003514848A (ja) 2003-04-22
CA2387575A1 (en) 2001-05-31
BR0015449A (pt) 2002-07-09
US8652517B2 (en) 2014-02-18
RU2002116225A (ru) 2004-01-20
IL149189A0 (en) 2002-11-10
US20060034917A1 (en) 2006-02-16
HUP0204072A2 (en) 2003-05-28
WO2001037816A3 (en) 2001-11-29
ES2255521T3 (es) 2006-07-01
TW579298B (en) 2004-03-11
HUP0204072A3 (en) 2004-06-28
TR200201028T2 (tr) 2002-10-21
SK6962002A3 (en) 2002-10-08
CN1391465A (zh) 2003-01-15
ATE315383T1 (de) 2006-02-15
NO20022362D0 (no) 2002-05-16
AU2358501A (en) 2001-06-04
NZ518524A (en) 2004-04-30
DE60025536T2 (de) 2006-08-10
MXPA02005195A (es) 2003-01-28
NO20022362L (no) 2002-07-11
AR026560A1 (es) 2003-02-19
CO5261638A1 (es) 2003-03-31
ZA200203654B (en) 2003-06-05
AU776662B2 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
PE20011009A1 (es) Proceso para recubrir nucleos de tabletas
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
NO985643L (no) Antimikrobielle blandinger
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2001032646A3 (en) Sulfonamide derivatives
MY133392A (en) Novel substituted pyrazole derivatives
BR0013507A (pt) Processo de revestimento de comestìveis usando uma mistura de isomaltulose hidrogenada
EE200200065A (et) 3-aminopürasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena ning neid sisaldav farmatseutiline kompositsioon
CA2268394A1 (en) New heterocyclylmethyl-substituted pyrazol derivates
EP0835655A4 (en) ANTIBACTERIAL / BACTERICIDAL / ANTISEPTIC AGENT, DERMATOLOGICAL PREPARATION AND SURFACTANT COMPOSITION
WO2004071538A3 (en) Topical delivery of cosmetic agents
FI793688A (fi) Hydroxipropyl-triazol foerfarande foer framstaellning av dem och deras anvaendning som laekemedel
AU2108500A (en) Galenic formulation containing biotin
PL324621A1 (en) Derivatives of colchicine, their application and pharmaceutic compositions containing them
AU5638200A (en) Tissue products having antiviral properties
TW200506003A (en) Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and confectionary using same
DK1119363T3 (da) Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel
CA2362698A1 (en) Resorcinol derivatives
PL1638582T3 (pl) Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej
WO1999026606A3 (en) SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
ATE472995T1 (de) Nicht therapeutische verwendung von n- acetylglucosamin zur hautschälung
FI945866A (fi) Ennaltaehkäisevä ja hoitava valmiste kariesta vastaan
EP1325903A4 (en) DERIVATIVES OF 2,3-DIPHENYLPROPIONIC ACID OR THEIR SALTS, MEDICAMENTS OR INHIBITORS OF CELL ADHESION CONTAINING THE SAME, AND THEIR USE
CA2366623A1 (en) Resorcinol composition
EE200100713A (et) Asendatud puriiniderivaadid, nende valmistamine ja kasutamine rakuadhesiooni inhibiitoritena ning neid sisaldav farmatseutiline kompositsioon

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed